AWA
DGX icon

Aaron Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Aaron Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Buy
3,531
+536
+18% +$105K 0.04% 320
2026
Q1 		$587K Sell
2,995
-4,045
-57% -$786K 0.03% 356
2025
Q4 		$1.22M Sell
7,040
-578
-8% -$105K 0.07% 209
2025
Q3 		$1.45M Buy
+7,618
New +$1.35M 0.09% 163
2022
Q2 		– Sell
-61,176
Closed -$447K – 358
2022
Q1 		$447K Buy
+61,176
New +$8.53M 0.01% 540

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Aaron Wealth Advisors's DGX Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Quest Diagnostics (DGX) stake by 18% in Q2 2026, buying an estimated $105K and bringing the position to 3,531 shares worth $748K. The position accounts for 0.04% of the portfolio, ranked #320.

Aaron Wealth Advisors first reported a position in DGX in Q1 2022 and has held it in 5 quarters since. The position peaked at $1.45M in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Aaron Wealth Advisors held 3,531 shares of Quest Diagnostics worth $748K as of Q2 2026.
  • Aaron Wealth Advisors bought 536 Quest Diagnostics shares in Q2 2026, an estimated $105K.
  • Quest Diagnostics made up 0.04% of Aaron Wealth Advisors's portfolio in Q2 2026, its #320 holding.
  • Aaron Wealth Advisors first reported a position in Quest Diagnostics in Q1 2022 and has held it in 5 quarters since.
  • Aaron Wealth Advisors's Quest Diagnostics position peaked at $1.45M in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.